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Diffuse large B-cell lymphoma (DLBCL) is more prevalent and more often fatal in HIV-infected patients and SIV-
infected monkeys compared to immune-competent individuals. Molecular, biological, and immunological data indicate 
that virus-associated lymphomagenesis is similar in both infected hosts. To find genes specifically overexpressed in 
HIV/SIV-associated and non-HIV/SIV-associated DLBCL we compared gene expression profiles of HIV/SIV-related  
and non-HIV-related lymphomas using subtractive hybridization and Northern blot analysis. Our experimental 
approach allowed us to detect two genes (a-myb and pub) upregulated solely in HIV/SIV-associated DLBCLs potentially 
involved in virus-specific lymphomagenesis in human and monkey. Downregulation of the pub gene was observed in 
all non-HIV-associated lymphomas investigated. In addition, we have found genes upregulated in both non-HIV- and 
HIV-associated lymphomas. Among those were genes both with known (set, ND4, SMG-1) and unknown functions. In 
summary, we have demonstrated that simultaneous transcriptional upregulation of at least two genes (a-myb and pub) 
was specific for AIDS-associated lymphomas. 
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1.  INTRODUCTION 
Lymphoid neoplasms represent a heterogeneous 
group of malignancies including Hodgkin's disease, non-
Hodgkin lymphomas (NHLs), various leukemias, and 
multiple myeloma. In recent years the molecular 
mechanism of lymphomagenesis has been studied 
intensively. The formation and progression of B-cell NHLs 
affect 3.5-12% of patients including diffuse large B-cell 
lymphomas (DLBCL) infected with the human 
immunodeficiency virus (HIV) [1, 2].  In individuals with 
AIDS DLBCL is 60 to 200-fold more likely to occur than in 
general population [3, 4]. Infection with simian 
immunodeficiency virus (SIV) in some monkeys also leads 
to B-cell NHLs pathologically and clinically similar to 
those of HIV-infected patients [5-8]. SIV-associated NHLs 
are therefore an appropriate model to study the role of 
immunodeficiency virus in lymphomagenesis.  
Molecular studies have revealed both similarities 
and differences between HIV-associated and non-HIV-
associated lymphomas [9-11]. Although overexpression of 
some genes in a large proportion of HIV-associated 
DLBCL as compared to spontaneous DLBCL has been 
reported [9], specific differences in gene expression have 
not yet been detected [11].   Thus the question whether 
unique mechanisms leading to HIV-associated NHLs do 
exist remains open.  
Recently, using PCR-based two-step subtractive 
hybridization we identified spectra of genes 
overexpressed in human HIV-associated lymphomas [12] 
and monkey SIV-associated lymphomas [13] as compared 
with B-lymphocytes from blood and lymph nodes of 
healthy individuals. To reveal the difference in gene 
expression and to find genes both up- and down-
regulated during the formation of the lymphomas, we 
performed subtractive hybridization with centroblastic 
and immunoblastic HIV-associated DLBCLs in both 
directions. Transcription levels of the genes overexpressed 
in HIV/SIV-associated lymphomas were compared with 
those in  human spontaneous lymphomas. The data 
obtained have revealed a specific difference in the 
expression pattern of several genes in HIV/SIV-associated 
as compared to non-HIV-associated (spontaneous) 
DLBCLs. 
2.  METHODS 
Tumor tissue and cells 
Biopsy specimens from two lymphomas (h1 and h2) 
from HIV-1-infected AIDS-patients (males, age 43 and 36, 
respectively) were kindly provided by Prof. Dr. I. Schedel, 
Medical School, Hannover, Germany [12]. The material 
from lymphoma h1 was taken from the left tonsil. The 
specimens from lymphoma h2 were taken from the liver 
hilus. The latter patient was classified as WR-6 stage of 
AIDS. The tumors were B-cell NHL of centroblastic type 
(lymphoma h1) and immunoblastic type (lymphoma h2). 
Cells from both tumors harbored Epstein-Barr virus 
genomes and contained EBER-1 and EBNA-2 mRNAs 
[14]. Three rhesus monkeys (M. mulatta) #1725, #7198 and 
#1153 (m1, m2, and m3, respectively) developed B-NHL 
after infection with SIVmac251 [13].  All samples were 
examined histologically and tissue blocks were trimmed 
to exclude areas of surrounding nonlymphoid tissues. 
Lymphoma biopsy specimens were stored at –80°C. Using 
RT-PCR, we analyzed the expression levels of the three 
oncogenes (bcl-2, bcl-6 and c-myc) and two suppressor 
gene (Rb и p53) both in the human and monkey AIDS-
related lymphomas. The expression profile of these genes Int. J. Med. Sci. 2005 2  123
was similar to that found in normal human B-
lymphocytes (data not shown).  
Spontaneous non-HIV-associated lymphoma biopsy 
specimens were provided by the Hematology Scientific 
Center of the Russian Academy of Medical Sciences. The 
characteristics of these tumors are summarized in Table 1. 
Human and monkey B-lymphocytes were isolated 
with LymphoSep (ICN Biomedicals) from peripheral 
blood of healthy donors and monkeys. 
Table 1. Characteristics of human spontaneous lymphomas 
## 
 
Subtype of lymphoma 
(REAL classification) 
Sex/Date of 
birth 
#3 (# 3860-864/01)  DLBCL  woman/1900 
#4 (# 956-998/01)  FL, stage II, mixed cells  woman/1945 
#5 (# 3681-3682/01)  FL man/1955 
#7 (# 1638-1644/00)  DLBCL woman/? 
#8 (# 2300-1766/01)  DLBCL man/1961 
#9 (# 1212-1216/01)  FL, stage I, preferentially small 
cells 
man/1936 
#10 (# 1537-1539)  DLBCL  man/1975 
#13 (# 334-336/01)  Nodular sclerotic HD  man/1971 
#14 (# 2218-
2219/00) 
Nodular sclerotic HD  man/1978 
DLBCL – diffuse large B-cell lymphoma; FL – follicular lymphoma; HD – 
Hodgkin’s disease 
RNA extraction, labeling, and hybridization 
Total cellular RNA was isolated from tissues and B 
lymphocytes dispersed in liquid nitrogen in the presence 
of 4 M guanidine isothiocyanate as described earlier [15].  
RNA was extracted twice with phenol, and its 
concentration was determined spectrophotometrically. 
The quality of the isolated RNA was confirmed by a 
horizontal agarose gel electrophoresis as well as by OD 
260/280 ratios. 
Table 2. The primers structure and the annealing temperatures 
used for PCR 
Gene Primers  Annealing,    t  oС
β-actin 5’-TGCTTCTAGGCGGACTATGAC-3’ 
5’-AGAAGTGGGGTGGCTTTTAGG-3’ 
64 
set 
 
5’-ACCTGGTTTACTGACCATTCTGA-3’ 
5’-TCTTCTTCACCTTCATCCTCATC-3’ 
59 
ND4 5’-TCCCCACCTTGGCTATCATC-3’ 
5’-TTGTTGGCTCAGGAGTTTGA-3’ 
60 
a-myb 5’-AAGAAGAATCAGGCACTCAACTG-3’ 
5’-GGAAGTGTTAGGGTTTGGTTTCT-3’ 
60 
capn4  5’-CCACAAGCTTTTGTTCTCTCAGTA-3’ 
5’-CACAGGTACAGGGGAGAGGTTAC-3’ 
60 
pub  5’-TACTGACCGAGTGCTGAGACTACT-3’ 
5’-GCAATTTGCCATATCAATAAAGAA-3’
60 
 
Northern blot analysis was performed as described 
earlier [12]. Membranes with RNA were UV irradiated 
and hybridized with [
32P]-labeled SalI-fragments of cDNA 
clones generated by subtraction combined with 
differential screening or with [32P]-labeled PCR-
fragments of the corresponding genes. As a control, we 
used a [32P]-labeled  β-actin PCR-amplification product. 
The nucleotide sequences of the primers are presented in 
Table 2. Dot-hybridization of the subtracted human cDNA 
library with radioactively labeled monkey cDNAs was 
performed as previously described [16]. cDNA and PCR-
fragments were labeled by the random-prime method 
(Prime-a-Gene Labeling System, Promega, USA). 
[32P]dCTP was obtained from Amersham International 
(Amersham, UK). The radioactive bands were quantified 
by Phosphorimager analysis (Molecular Dynamics, USA). 
Subtractive cloning 
A PCR-based technique was performed. A detailed 
protocol how to generate cDNA libraries,  isolation of 
lymphoma-specific cDNA by subtractive hybridization 
and the differential screening was published previously 
[13].    I n  t h e  p r e v i o u s  s t u d y  [ 1 2 ]  w e  u s e d  R N A s  f r o m  
lymphoma h1 and h2 cells as tracer and driver, 
respectively. In this study, RNA from lymphoma h1 cells 
was used as driver, and RNA from lymphoma h2 cells as 
tracer.   
Sequencing of DNA and analysis 
Cloned cDNAs were sequenced using an Amersham 
Quick-Denature-Plasmid-Sequencing Kit. A search for 
similarity of the subtracted sequences with known 
sequences was performed with the BLAST DataBase. 
3.  RESULTS 
Different factors and a variety of genes may 
contribute to the chain of events that eventually lead to 
lymphomagenesis. In an initial study to identify genes 
differentially transcribed in HIV and SIV-associated 
DLBCLs we employed a two-step subtractive 
hybridization using the RNA from lymphoma cells of 
HIV/SIV-infected individuals as tracer and as driver the 
RNA from B lymphocytes of an uninfected human and 
monkey [12, 13].  However, it remained to be elucidated 
whether enhanced transcription of some genes in these 
lymphomas was associated with the malignant 
transformation of these cells or with another factors, such 
as different proliferation rates of the cell populations 
examined. Another open question is whether there are 
differences in the expression of genes in HIV/SIV-related 
and spontaneous lymphomas. 
To address these questions, the subtraction 
hybridization between the two human HIV-related 
lymphomas (h1 and h2) cDNAs was performed in both 
directions: 1) the cDNA population of lymphoma h1 as 
tracer, and the cDNA population of lymphoma h2 as 
driver; and vice versa, 2) the cDNA population of 
lymphoma h2 as tracer, and the cDNA population of 
lymphoma h1 as driver.  
The cDNAs selected by the two-step differential 
screening were sequenced and compared with nucleotide 
sequences available in BLAST Databases. Partial 
preliminary data concerning the first subtraction were 
published [12].  The  complete  results of two subtractive 
hybridizations in both directions are given in Table 3.  
A comparison of their sequences allowed us to 
subdivide the cDNAs into two groups. The first group 
includes cDNAs selected both by subtractive 
hybridization between the two lymphomas (Table 3) and 
between lymphomas and B-lymphocytes [12] (the set 
oncogene, constant part of the λIg gene, the mitochondrial 
genes of NADH dehydrogenase subunit 4 (ND4), the 
interferon-inducible gene 6-16 (Inf-ind), the 16S rRNA gene 
(most probably the humanin  gene [17]). These results 
confirmed the adequacy of our method and suggested 
that the use of RNA from B-lymphocytes was quite 
applicable for the detection of B-cell lymphomas specific 
gene expression.  
Table 3. cDNA nucleotide sequences selected by two-step 
hybridization and subsequent two-step differential screening of 
cDNA populations from lymphoma h1 and h2 as overexpressed Int. J. Med. Sci. 2005 2  124
both in each lymphoma  in comparison with the other 
lymphoma and human normal B-lymphocytes 
HIV-associated 
DLBCL 
The differentially transcribed 
genes 
NCBI Acc N 
set  M93651 
a-myb  X66087 
IL4R X54425 
IL5 BG599356 
capn4  X04106 
ND4 V00662 
TAP2 U07844 
HnRNP A1  BG644331 
16S rRNA (humanin) AY011166 
IFN-ind U22970/X14583
λIg X14583 
γIg M63438 
KIAA1536 AB040969 
DKFZp547I094 AK024405 
FLJ20554 AK000561 
FLJ23277 AK026930 
EST BG599355 
EST BG599357 
EST BG599358 
 
 
 
 
 
 
h1 
EST BG599359 
SMG-1 CB252001 
ribosomal protein S8  CB252002 
KIAA1350  AB037771 
FLJ20306  NM017756 
FLJ39323 fis  АК096642 
FLJ14117  BC038668 
FLJ30053 fis  АК054615 
 
 
 
h2 
EST  CB252000 
capn4 – the calpain subunit 4 gene,  ND4 – the NADH dehydrogenase subunit 4 
gene, IL5 – the interleukin 5 gene, λIg – the λ-chain of immunoglobulin gene, 
γIg – the γ-chain of immunoglobulin gene, IFN-ind – the interferone-inducible 
gene 6-16, IL4R – the interleukin 4 receptor gene, TAP2 – the transport protein 
gene, hnRNP A1 – the human ribonucleoprotein А1 gene; SMG-1 – the 
phosphatidylinositol kinase (PIK)-related kinase 1 gene, EST – expressed 
sequenced tags. 
 
The second group represents those cDNAs that were 
only revealed by subtractive hybridization between two 
HIV-related lymphomas. In this group of upregulated 
genes there were the a-myb oncogene, the interleukin 4 
receptor gene (IL4R), the gene of the transporter protein 
TAP2, the gene of protease calpain 4 small subunit (capn4) 
and other (in case of lymphoma h1) and SMG-1, the gene 
of ribosomal protein S8 (in case of lymphoma h2), as well 
as several genes of unknown function  (9 and 8 in the case 
of lymphoma h1 and h2, respectively). The latter genes 
may represent new genes associated with 
lymphomagenesis but undetectable by microarray.  
Differences in expression of genes of the second 
group might be due to different origin and molecular 
mechanisms acting in these two types of human HIV-
associated DLBCL. Perhaps the subtraction performed 
would hardly shed light on the role of HIV in the 
development of lymphomas, and it would be better to 
subtract HIV-associated DLBCL cDNAs from those of 
spontaneous DLBCL.  But in earlier experiments, such a 
difference was not detected [11]. We have suggested that 
at least some of the genes preferentially expressed in one 
of these lymphomas might be involved in HIV-associated 
lymphomagenesis, and this suggestion was confirmed. 
  We found earlier that some genes (set,  COX-II) 
highly expressed in one of DLBCL, as compared to B-cells, 
were actually upregulated in both HIV-associated 
lymphomas [12]. The expression of several genes isolated 
with subtractive hybridization between h1 and h2 (Fig 1, 
see also [12]) was evaluated using Northern blot analysis 
in both human lymphomas and human B-lymphocytes. 
The expression of the a-myb oncogene was shown to be 
higher (about 5 times) in lymphoma h1 (lane h1) than in 
lymphoma h2 (lane h2), but in both cases higher (about 5-
10 times) than in human B-lymphocytes (lane B) (Fig. 1) 
when normalized by β-actin hybridization to these filters). 
Likewise, the expression levels of the SMG-1 and capn4 
genes in both lymphomas were also higher (about 2-3 
times) than those in normal B-lymphocytes. 
Figure 1. Northern blot analysis of differential transcription in 
human HIV-associated lymphomas h1 and h2, monkey SIV-
associated lymphomas m1, m2, m3, and  human normal B-
lymphocytes. 
32P-labeled PCR-fragments of the a-myb oncogene 
or the SMG-1  gene were hybridized to RNA from human 
normal B-lymphocytes (lane B), human HIV-associated 
lymphomas h1 (lane h1) and h2 (lane h2), monkey SIV-
associated lymphomas m1 (lane m1), m2 (lane m2), and m3 
(lane m3). Rehybridization with a 
32P-labeled PCR-fragment of 
β-actin gene was used as control (bottom). 
 
Macaques infected with SIV are an appropriated 
animal model for HIV infection and AIDS of humans [5-8, 
13]. We supposed that some genes were overexpressed 
both in HIV- and SIV-associated lymphomas. Using dot 
and blot hybridization, transcription of genes upregulated 
in human HIV-associated lymphoma was studied in three 
SIV-associated monkey lymphomas and monkey B-
lymphocytes. To this end, about 100 cDNAs from 
subtracted human cDNA libraries of lymphomas h1 and 
h 2  w e r e  a n a l y z e d  b y  d o t  blot hybridization with 
[32P]-labeled cDNA populations from SIV-associated 
monkey lymphomas and monkey B-lymphocytes. Those 
cDNAs whose hybridization signals were markedly 
s t r o n g e r  w i t h  l y m p h o m a  c D N A  t h a n  w i t h  c D N A  o f  B -
lymphocytes were further analyzed by Northern blot 
hybridization. Some genes (a-myb, set, SMG-1, ND4) 
involved in HIV-associated lymphomagenesis were 
overexpressed in one or more SIV-associated lymphomas 
(Tables 4, 5). Their transcription in other SIV-associated 
lymphomas was unchanged or even downregulated. For 
example, Fig. 1 shows that the transcription of the SMG-1 
gene was 8 fold upregulated in lymphoma m2, unchanged 
in lymphoma m3 and even downregulated (no 
expression) in lymphoma m1 (lanes m1, m2, and m3). The 
a-myb oncogene was about 2.5-7 fold overexpressed in all 
SIV-associated monkey lymphomas (Fig. 1, lanes m1, m2, 
and m3). However, the capn4 gene was not transcribed in 
SIV-associated lymphomas. The results obtained were in 
accord with our earlier results of Northern blot 
hybridization with SIV-associated monkey mRNA [13]. Int. J. Med. Sci. 2005 2  125
Earlier we identified the pub gene as upregulated in 
SIV-associated monkey DLBCL [13].  The pub gene (also 
known as KIAA0129 or TRIM14) was previously found to 
be expressed in the human myeloid cell line KG-1 [18]. 
Northern blotting with RNAs from SIV-associated 
monkey lymphomas [13] demonstrated overexpression of 
the  pub gene in the cells of all three SIV-associated 
monkey lymphomas as compared to B-lymphocytes. 
Northern blot hybridization of a PCR-fragment of pub 
with RNA from human HIV-associated lymphomas h1 
and h2 and B-lymphocytes revealed increased levels of 
this gene transcription in both these human lymphomas 
(in lymphoma h1 higher than in h2) [16].  The two genes 
(a-myb and pub) were thus overexpressed both in human 
HIV-associated and monkey SIV-associated lymphomas 
and seemed to be common for virus-specific 
lymphomagenesis in human and monkey.  
Table 4. Selected human HIV-associated lymphomas h1 and h2 
genes overexpressed in SIV-associated monkey lymphomas in 
comparison with monkey B lymphocytes (results of the blot- 
and dot-hybridization) 
Genes   NCBI Acc N 
set  M93651 
a-myb  X66087 
IL4R X54425 
ND4 V00662 
pub  D50919 
TAP2 U07844 
HnRNP A1  BG644331 
λIg X14583 
KIAA1536 AB040969 
DKFZp547I094 AK024405 
FLJ23277 AK026930 
EST  CB252000 
EST  CB252001 
 
To find genes specifically overexpressed in HIV/SIV-
associated and/or non-HIV/SIV-associated DLBCLs, we 
compared transcription levels of the selected genes in 
HIV/SIV-associated and human non-HIV-associated 
(spontaneous) lymphomas. Northern blot hybridization of 
several genes with RNAs from 9 spontaneous 
human lymphomas (4 - DLBCL, 3 - follicular 
lymphomas (FL), 2 - Hodgkin’s disease (HD)) is 
presented in Fig. 2a, 2b and Table 5.  
Figure 2. Northern blot analysis of the transcription 
levels of the set,  ND4, and SMG-1 genes in human 
spontaneous lymphomas and normal B- and T-
lymphocytes. (a) 
32P-labeled PCR-fragments of the set 
and a-myb oncogenes, and ND4, pub and capn4 genes 
were hybridized to RNA from human normal B-
lymphocytes (lane B), T-lymphocytes (lane T), human 
spontaneous DLBCLs # 3, 7, 10 (lanes 3, 7, 10), FL # 4, 
5, 9 (lanes 4, 5, 9), HD # 13, 14 (lanes 13, 14). (b) A 
32P-labeled  SalG1-fragment of a cDNA clone 
homologous to the SMG-1 gene was hybridized to RNA 
from human normal B-lymphocytes (lane B), human 
spontaneous DLBCLs # 7, 10 (lanes 7, 10), FL # 5, 9 
(lanes 5, 9), HD # 13, 14 (lanes 13, 14). 
Rehybridization with a 
32P-labeled PCR-fragment of β-
actin gene was used as control (bottom). 
 
Table 5. Summary of gene expression levels in human non-
HIV-associated and HIV/SIV-associated lymphomas (in 
comparison with normal B-lymphocytes) 
The genes 
upregulated only 
in 
virus-associated 
lymphomas 
The genes upregulated in 
virus-associated and 
spontaneous lymphomas 
 
Lymphomas 
a-myb  pub  capn4 set  ND4  SMG1 
h1 
(DLBCL) 
++ + ++  ++  ++  +  HIV-
associated 
h2 
(DLBCL) 
+ + +  +  +  ++ 
m1 
(DLBCL) 
+ ++ N  +  +  - 
m2 
(DLBCL) 
+++ ++  N  N  +  ++ 
SIV-
associated 
m3 
(DLBCL) 
+ + N  +  +  + 
#3 
(DLBCL) 
N - N  +  +  N 
#7 
(DLBCL) 
N - N  +  +  + 
#8 
(DLBCL) 
N - N  +  +  N 
#10 
(DLBCL) 
N - N  +  +  - 
#4 (FL)  N  -  N  +  +  + 
#5 (FL)  N  -  N  +  N  + 
#9 (FL)  N  -  N  N  -  + 
#13 (HD)  N  -  N  N  N  + 
 
 
 
non-HIV-
associated 
#14 (HD)  N  -  N  +  +  N 
“+”, “++” – upregulation, “-” – downregulation, “N” – no changes, DLBCL – 
diffuse large B-cell lymphoma, FL – follicular lymphoma, HD – Hodgkin’s 
desease, EST (NCBI Acc N CB252001) 
 
The results indicated that the set oncogene was 
transcribed 2-6 times more abundantly in several non-
HIV-associated lymphomas (as compared with normal 
human B-lymphocytes) including all DLBCLs  (# 3, 7, 8, 
10), some FLs (# 4, 5) and HDs (# 14). The gene of the 
mitochondrial NADH dehydrogenase subunit 4 (ND4) 
was 2-4 times overexpressed in all analyzed spontaneous 
DLBCLs (# 3, 7, 8, 10), and in some FL (# 4) and HD (# 14). 
The SMG-1 gene was highly transcribed in DLBCL # 7, in Int. J. Med. Sci. 2005 2  126
FLs # 5, 9 and in HDs # 13, 14. In lymphomas # 5 and 7 
SMG-1 transcripts of different length were formed 
(possible this is result of alternative splicing of mRNA). 
However, Northern blot analysis revealed no 
transcription of the a-myb and capn4 genes in non-HIV-
associated lymphomas and B-lymphocytes (Fig. 2a). The 
pub gene was slightly transcribed in B-lymphocytes and 
not transcribed in all non-HIV-associated  lymphomas 
(Fig. 2a). 
Thus, three genes (a-myb, pub, capn4) are upregulated 
exclusively in HIV-associated DLBCLs and probably 
specific for these lymphomas. Two of them (a-myb, pub) 
were found upregulated also in SIV-associated DLBCLs. 
The  pub gene was downregulated in all non-HIV-
associated lymphomas analyzed. Also, we revealed a set 
of genes (set,  ND4, SMG-1) which upregulated both in 
non-HIV-associated and in HIV/SIV-associated 
lymphomas.  
4.  DISCUSSION 
Our studies were aimed at the detection of new 
genes involved in the process of lymphomagenesis. 
Numerous approaches have been proposed to identify 
and analyze genes differentially expressed in cancer cells 
and particularly in lymphomas [9, 11-13, 19-22].  These 
techniques allowed to detect sets of genes up- or 
downregulated in malignant cells used as diagnostic 
markers to characterize different types of lymphomas. The 
cDNA microarray technology [19-22] has allowed the 
investigation of global gene expression profiles in cancer. 
Although cDNA microarray is a powerful tool for the 
identification of differentially expressed genes, this 
methodology has several potential limitations [22]. 
To identify genes differentially expressed in 
HIV/SIV-associated lymphomas, we used the PCR-based 
two-step subtractive hybridization.  This method does not 
need any previously cloned cDNA sets and allows to 
detect unknown genes. However, it remained to be 
elucidated whether enhanced transcription of some genes 
in lymphomas detected by this approach was associated 
with malignant transformation or with other factors, e.g. 
different proliferation rates of the cell populations 
examined. To answer this question, we performed 
subtractive hybridization between DLBCLs from two 
different AIDS-patients. The results of several 
independent experiments demonstrated that many of the 
genes revealed by us previously were also upregulated in 
the two lymphoma types. In HIV-associated lymphomas 
h1 and h2, some upregulated cDNA clones were found to 
be homologous to known genes including the set and a-
myb oncogenes, genes of ND4, IL4R, IL5, SMG-1, 
ribosomal protein S8, immunoglobulins, 
ribonucleoprotein hnRNP A1, transport protein ТАР2, 
CAPN4, etc. In addition, 17 overexpressed clones 
homologous to expressed sequence tags (ESTs) were 
detected. They may represent novel genes whose 
transcription is upregulated in lymphomas. A number of 
the genes detected in these experiments have not been 
previously associated with DLBCL of different origin. 
A comparison of expression profiles of some of these 
genes with those for the genes revealed earlier by 
subtractive hybridization in SIV-associated lymphomas 
[13] were very similar (Tables 4 and 5). About 10 genes 
were found to be overexpressed both in HIV- and  SIV-
related lymphomas. 
To find genes specific for HIV/SIV-associated 
and/or non-HIV/SIV-associated DLBCLs, we examined 
the expression levels of these 10 upregulated genes in 
spontaneous lymphomas. The results obtained (Table 5) 
allowed us to subdivide these genes into two groups. 
Firstly, we detected three genes (a-myb, pub, capn4) 
upregulated exclusively in human HIV-associated 
DLBCLs (and not in spontaneous lymphomas) and 
apparently specific for these DLBCLs. Transcription levels 
of the lymphoma-specific genes in three SIV-associated 
DLBCLs showed that two genes (a-myb, pub) of this group 
were overexpressed also in SIV-associated DLBCLs and 
might be involved in virus-specific lymphomagenesis in 
human and monkey. Secondly, the transcription of set, 
ND4, SMG-1 was increased in most HIV- and non-HIV-
associated lymphomas. These genes may be involved in 
both HIV-associated and non-HIV-associated 
lymphomagenesis. Some genes of this group (set, SMG-1, 
ND4) were overexpressed at least in one SIV-associated 
lymphoma, in the other SIV-associated lymphomas 
investigated their expression was unchanged or even 
downregulated.  
Moreover, we compared the expression of the 
selected lymphoma specific genes in normal human 
T-lymphocytes and the Jurkat T-cell line. Expression of set, 
SMG-1, and ND4 was unchanged, and pub and a-myb were 
not transcribed in normal human T-lymphocytes and the 
Jurkat cells (data not shown). These results suggested an 
association of the former genes exclusively with B cell but 
not T cell lymphomas. 
Attempts to reveal genes overexpressed  in HIV-
related DLBCL versus DLBCL have already been reported 
[9, 11]. Preliminary evidence for the high and specific 
expression of the TCL-1  proto-oncogene in HIV-related 
lymphomas [9] was confirmed only partially [11]. In 
contrast to our data, genes specifically expressed in AIDS-
related lymphomas were not detected. This contradiction 
is most likely explained by technical differences. For 
example, Patrone et al. [11] arbitrarily excluded some 
apparently “uninteresting” genes. But we have shown 
earlier that genes like ATP synthase, cytochrome b, 
cytochrome c oxidase,  and 16S rRNA are specifically 
upregulated in lymphomas [12, 13].  Also, the gene named 
16S RNA most probably relates to the humanin gene [17], 
since its transcript contains poly(A).  
According to our data (Tab. 5) a-myb  was 
overexpressed in all AIDS-related lymphomas.  At the 
same time, transcription of a-myb is un changed o r even 
reduced in all non-AIDS-related lymphomas analyzed 
here. a-myb  overexpressed in many cancer cells and in 
several germinal center (GC) B-like DLBCL  [19, 23]. 
Among the other genes (bcl-6, bcl-7A) the a-myb defined 
subtype GC B-like DLBCL but it was not a general rule. 
The a-myb product is known to upregulate bcl-2 in various 
lymphomas and to maintain the expression of c-myc in 
mouse B cell lymphoma [24]. Both these gene upregulated 
mainly in subtype activated B-like DLBCL [19]. Using RT-
PCR, we analyzed the expression levels of the three 
oncogenes (bcl-2, bcl-6 and c-myc) both in the human and 
monkey AIDS-related lymphomas. The expression profile 
of these genes was similar to that found in normal human 
B-lymphocytes. This suggested that AIDS-related 
lymphomas have been hardly referred to any definite 
subtype of DLBCL. 
Some of the genes we identified have not been 
implicated previously in DLBCL. According to our data Int. J. Med. Sci. 2005 2  127
the pub gene, also known as KIAA0129 or TRIM14, was 
overexpressed only in AIDS-related DLBCL, whereas its 
transcription was downregulated in all non-HIV-
associated lymphomas (Table 5). No reports on 
transcription levels of pub gene in lymphomas were 
previously available. This gene was earlier identified in 
the human myeloid KG-1 cell line [18]. Recently, it was 
shown, that pub is predominantly transcribed in 
hematopoietic tissues and inhibits the activity of the PU.1 
transcription factor important for B-lymphocytes 
differentiation and proliferation [25]. Our data suggest 
that the pub  gene simultaneously with a-myb  may be 
involved in malignant transformation of B cells in 
HIV/SIV-associated DLBCL.  
We have shown that the gene coding for the small 
subunit of calcium-dependent cysteine proteinase calpain 
4 (capn4) is upregulated in both HIV-associated 
lymphomas, but not SIV-associated lymphomas. The role 
of calpains in apoptosis was studied almost exclusively. 
However, calpain inhibits apoptosis in acute 
lymphoblastic leukemia cells and might be associated 
with malignization of these cells [26]. Recent studies of 
unusual effects of calpains in cancer cells [27-29] suggest 
that calpain participates in cell malignization by digesting 
the p53 tumor suppressor. Besides, calpains participate in 
induction of HIV replication [30]. However, there are no 
data on overexpression of capn4 in spontaneous DLBCLs. 
These and our data suggest that capn4 is a candidate gene 
specific for human HIV-associated lymphomas. 
We have also detected a high level transcription of 
set ( TAF-1, template activating factor-1) in both HIV-
associated and non-HIV-associated lymphoma tissues. 
The SET protein is highly homologous to NAP 
(nucleosome assembly protein). Alternative splicing of set 
mRNA leads to the formation of at least two protein 
forms, TAF-1α and TAF-1β [31], the latter being the SET 
protein.   SET/TAF-1β is a member of the INHAT 
(inhibitor of histone acetyltransferase) complex. SET is 
also an inhibitor of protein phosphatase 2A [32]. 
Inhibition of this phosphatase induces an increase in 
telomerase activity known to be involved in cell 
immortalization [33].  We detected an enhanced 
transcription of the set gene (the only 780 bp long mRNA 
coding for SET/TAF-1β) both in HIV/SIV-associated and 
several spontaneous human lymphomas. Microchip 
studies also revealed that set was highly expressed in 
human spontaneous DLBCLs [19].  Thus enhanced 
expression set might be associated with the malignisation 
of germinal center-derived large B cells of different origin.  
The human HIV-associated and monkey SIV-
associated lymphomas analyzed overexpressed a limited 
set of mitochondrial genes of the oxidative 
phosphorylation pathway [12,13].    We demonstrated 
changes in the expression of ND4 mitochondrial genes in 
various lymphomas. It is difficult to discriminate whether 
this phenomenon is a cause or a consequence of 
oncogenesis. But our experiments with immortalized 
fibroblasts, used as a model of early stage of oncogenesis, 
suggest that enhanced transcription of mitochondrial 
genes can be associated with the early stages of 
oncogenesis [34].  
The  SMG-1 kinase gene was upregulated in one 
human HIV-associated, one monkey SIV-associated and 
several human non-HIV-related lymphomas. Previously, 
this gene was not associated with lymphomas 
development. The SMG-1 kinase is a member of the 
phosphatidylinositol kinase (PIK)-related kinase family 
involved in nonsense-mediated mRNA decay [35]. The 
defective SMG-1 kinase may contribute to the process of 
malignant transformation in B-cell lymphomas of 
different origin.  
In conclusion, using subtractive hybridization we 
detected three genes (a-myb, pub and capn4) upregulated 
predominantly in HIV-associated DLBCLs. So far, the 
only known gene presumably specific for HIV-associated 
immunoblastiс plasmacytoid lymphomas was TCL1  [9].  
The study the role of the immunodeficiency virus in 
lymphomagenesis, we measured the transcription levels 
of human lymphoma-specific genes in SIV-associated 
DLBCLs thought to be an appropriate model. Two of the 
three genes (a-myb,  pub) upregulated in HIV-related 
lymphomas were overexpressed in SIV-associated 
lymphomas and might be simultaneous involved in virus-
specific lymphomagenesis in man and monkey.  All genes 
detected might be specifically upregulated in HIV-
associated DLBCLs and these are targets for therapy of 
these lymphomas. The set, ND4 and SMG-1genes involved 
in both spontaneous and HIV/SIV-associated 
lymphomagenesis. The latter two genes have not been 
implicated previously in DLBCL. 
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